title: Association of anti-IL-12/23 biologic agents ustekinumab and briakinumab with major adverse cardiovascular events.
authors: Division of Evidenced-Based Dermatology, Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany; Department of Pharmacology and Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
authors: T
authors: T
authors: Tzellos
authors: A
authors: A
authors: Kyrgidis
authors: A
authors: A
authors: Trigoni
authors: C C
authors: CC
authors: Zouboulis
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal